A French startup built a radiology viewer from scratch with AI at its core. Moffitt Cancer Center is already using it.

TL;DR

Paris-based Raidium launched its AI-native radiology platform at Moffitt Cancer Center. Its Curia model automates tumor tracking and cuts reader variability by 3x.

Raidium, a Paris and Silicon Valley-based radiology startup, has launched its AI-native imaging platform in the US at Moffitt Cancer Center, one of the country’s leading oncology research institutions. The platform, called Raidium Read, replaced Moffitt’s legacy radiomics applications and is currently available for clinical trials and research use. FDA 510(k) clearance is expected before the end of 2026.

The system is built around Curia, Raidium’s proprietary foundation model trained on over 200 million CT and MRI slices from 150,000 exams. Instead of layering AI tools on top of an existing PACS viewer, the company built the viewer itself from scratch with the model embedded. Curia performs organ-agnostic, automated RECIST measurements, the standardised method for tracking tumor response to treatment, across multiple time points. Raidium...

Copyright of this story solely belongs to thenextweb.com. To see the full text click HERE